Loading organizations...
§ Private Profile · Köln, Nordrhein-Westfalen, Germany
Licensing human cell-based expression systems for therapeutic proteins, gene therapy vectors, and antibodies with human glycosylation.
CEVEC Pharmaceuticals is a Cologne, Germany-based biotechnology company that develops and licenses proprietary human cell-based expression systems for the production of complex therapeutic proteins, monoclonal antibodies, and gene therapy vectors. The organization utilizes its proprietary CAP and CAP-T technologies to provide human glycosylation patterns, addressing the limitations commonly associated with traditional non-human cell production methods. Operating with a workforce of approximately 30 employees, the firm focuses its commercial efforts on the broader biopharmaceutical manufacturing industry through flexible technology licensing agreements and strategic co-development partnerships. Key figures involved in the company's corporate governance and executive leadership have included notable industry professionals such as Nicole Faust, Wolfgang Kintzel, and supervisory board member Rainer Christine. CEVEC Pharmaceuticals was officially founded in 2001 by Stefan Kochanek alongside a group of research scientists and clinicians from the University of Cologne.
CEVEC Pharmaceuticals has raised $19.4M across 3 funding rounds.
CEVEC Pharmaceuticals has raised $19.4M in total across 3 funding rounds.
CEVEC Pharmaceuticals has raised $19.4M across 3 funding rounds. Most recently, it raised $4.9M Other Equity in July 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 30, 2015 | $4.9M Venture Round | — | Frank Ubags, Nicole Faust, G.A.T. Holding, Investtodate, KFW, NRW.BANK, Peppermint Venture Partners | Announced |
| Jul 25, 2011 | $8.6M Venture Round | NRW.BANK | KFW | Announced |
| Nov 4, 2009 | $5.9M Venture Round | NRW.BANK | KFW, Sparkasse KoelnBonn | Announced |
CEVEC Pharmaceuticals has raised $19.4M in total across 3 funding rounds.
CEVEC Pharmaceuticals's investors include frank ubags, Nicole Faust, G.A.T. Holding, Investtodate, KfW, NRW.BANK, Peppermint Venture Partners, Sparkasse KoelnBonn.